| Roche will publish its Sales Results for the 3rd Quarter of 2016 prior to the opening of the Swiss Stock Exchange on Thursday, 20th October 2016. |
| 07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before) |
Release will be e-mailed and posted on the Roche IR website  click here. |
| Presentation slides will be posted on the Roche IR website click here. |
We would like to invite all interested parties to dial in as outlined below:
14:00 - 15:15 CEST / 13:00 - 14:15 BST 08:00 - 09:15 AM EDT / 05:00 - 06:15 AM PDT |
| Conference call will start with presentations by senior management followed by a Q&A session(live access to the speakers). |
Presenters: |  | Severin Schwan, CEO Roche Group | | Daniel O'Day, CEO Pharmaceuticals | | Roland Diggelmann, CEO Diagnostics | | Alan Hippe, Chief Financial and IT Officer |
|
| To expedite the registration process on the day of the conference call, you may pre-register for the event by clicking > here |
| Alternatively you may dial in to the conference 10-15 min prior to the scheduled start, using the following numbers: | | +41 (0) 58 310 5000 (Europe and ROW)) | | +44 (0) 203 059 5862 (UK) | | +1 (1) 631 570 5613 (USA) |
|
| A live audio webcast can be accessed via > ir.roche.com. |
| A replay of the webcast will be available on demand at > ir.roche.com. |
| Best regards, |
Karl Mahler
Head of Investor Relations |
